Dilafor believes that healthier labor contributes to healthier lives for mothers, children and families.

Dilafor is dedicated to the development of pharmaceutical products aimed at minimizing the risk for protracted labor and associated complications. Dilafor develops pharmaceutical products from heparin derivatives with low anticoagulant activity. The company has a balanced product portfolio representing some highly promising ideas and innovations in obstetrics.